Found: 36
Select item for more details and to access through your institution.
Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 11, p. 1681, doi. 10.1007/s00432-010-0826-7
- By:
- Publication type:
- Article
Author Correction: COLONOMICS - integrative omics data of one hundred paired normal-tumoral samples from colon cancer patients.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
COLONOMICS - integrative omics data of one hundred paired normal-tumoral samples from colon cancer patients.
- Published in:
- Scientific Data, 2022, v. 9, n. 1, p. 1, doi. 10.1038/s41597-022-01697-5
- By:
- Publication type:
- Article
Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic Disease.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.792609
- By:
- Publication type:
- Article
Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer.
- Published in:
- Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-46
- By:
- Publication type:
- Article
Neuropatía periférica producida por taxanos y calidad de vida global en pacientes con cáncer de mama.
- Published in:
- Metas de Enfermería, 2018, v. 21, n. 3, p. 67
- By:
- Publication type:
- Article
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00351-4
- By:
- Publication type:
- Article
The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00282-0
- By:
- Publication type:
- Article
Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00223-x
- By:
- Publication type:
- Article
Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00216-w
- By:
- Publication type:
- Article
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-020-00208-2
- By:
- Publication type:
- Article
Absence of large intragenic rearrangements in the DPYD gene in a large cohort of colorectal cancer patients treated with 5-FU-based chemotherapy.
- Published in:
- British Journal of Clinical Pharmacology, 2010, v. 70, n. 2, p. 268, doi. 10.1111/j.1365-2125.2010.03683.x
- By:
- Publication type:
- Article
ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1902, doi. 10.3390/cancers12071902
- By:
- Publication type:
- Article
Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Gene expression profiles of breast cancer metastasis according to organ site.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 1, p. 69, doi. 10.1002/1878-0261.13021
- By:
- Publication type:
- Article
First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.744112
- By:
- Publication type:
- Article
Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer Patients.
- Published in:
- Clinical Chemistry, 2017, v. 63, n. 3, p. 751, doi. 10.1373/clinchem.2016.265314
- By:
- Publication type:
- Article
Identification of candidate susceptibility genes for colorectal cancer through eQTL analysis.
- Published in:
- Carcinogenesis, 2014, v. 35, n. 9, p. 2039, doi. 10.1093/carcin/bgu092
- By:
- Publication type:
- Article
Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple‐negative early breast cancer: Primary translational analysis of the WSG‐ADAPT‐TN trial.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 1, p. 262, doi. 10.1002/ijc.32488
- By:
- Publication type:
- Article
Discovery and Functional Assessment of Gene Variants in the Vascular Endothelial Growth Factor Pathway.
- Published in:
- Human Mutation, 2014, v. 35, n. 2, p. 227, doi. 10.1002/humu.22475
- By:
- Publication type:
- Article
Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00625-7
- By:
- Publication type:
- Article
Author Correction: Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Everolimus plus Exemestane for Hormone Receptor‐Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO‐2.
- Published in:
- Oncologist, 2019, v. 24, n. 7, p. 893, doi. 10.1634/theoncologist.2018-0407
- By:
- Publication type:
- Article
Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE<sub>2</sub> in colorectal cancer.
- Published in:
- Clinical Epigenetics, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13148-015-0110-4
- By:
- Publication type:
- Article
Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Large differences in global transcriptional regulatory programs of normal and tumor colon cells.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-708
- By:
- Publication type:
- Article
Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer.
- Published in:
- Bioinformatics, 2016, v. 32, n. 7, p. 1097, doi. 10.1093/bioinformatics/btv693
- By:
- Publication type:
- Article
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 1, p. 69, doi. 10.1093/jnci/djad179
- By:
- Publication type:
- Article
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 3, p. 332, doi. 10.1093/jnci/djac227
- By:
- Publication type:
- Article
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Corrigendum: PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00707
- By:
- Publication type:
- Article
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-019-14111-3
- By:
- Publication type:
- Article
Large differences in global transcriptional regulatory programs of normal and tumor colon cells.
- Published in:
- 2014
- By:
- Publication type:
- journal article